The investment will expand RNA T&T's operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics.

Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based and privately held RNA Technologies & Therapeutics in a move to scale the latter’s operations around ...

A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled “A ...

Biologists mapping the human microbiome expected to find new bacteria and viruses, not entities that slip through every ...

The new findings strengthen the "RNA world" hypothesis that describes how the first life on Earth could have used RNA instead ...

A research team has developed a new RNA-based system that can detect coronavirus infection in real time inside living cells—and even trigger antiviral responses only when infection occurs.

Researchers have identified key drivers of T cell development which promote resilience to influenza virus infection. Scientists at the Babraham Institute have shown that two RNA binding proteins hold ...

Using a novel method, Weizmann Institute of Science researchers map 16 types of simultaneous changes in dozens of samples; findings can lead to improved RNA-based medical technologies The post Israeli ...

This is the second of two articles on a temperature-sensitive self-replicating RNA vaccine; click here for part one. They form part of a broader series on next-generation mRNA vaccines. The first ...